Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo

Free Radic Biol Med. 2019 Aug 1:139:80-91. doi: 10.1016/j.freeradbiomed.2019.05.011. Epub 2019 May 10.

Abstract

Oxidative stress and effector memory CD8+ T cells have been greatly implicated in vitiligo pathogenesis. However, the crosstalk between these two crucial pathogenic factors has been merely investigated. IL-15 has been regarded as an important cytokine exerting its facilitative effect on memory CD8+ T cells function in various autoimmune diseases. In the present study, we initially discovered that the IL-15 expression was significantly increased in vitiligo epidermis and highly associated with epidermal H2O2 content. In addition, epidermal IL-15 expression was mainly derived from keratinocytes. Then, we showed that oxidative stress promoted IL-15 and IL-15Rα expression as well as IL-15 trans-presentation by activating NF-κB signaling in keratinocytes. What's more, the trans-presented IL-15, rather than the secreted one, was accounted for the potentiation of CD8+ TEMs activation. We further investigated the mechanism underlying trans-presented IL-15 in potentiating CD8+ TEMs activation and found that the blockage of IL-15-JAK-STAT signaling could be a potent therapeutic approach. Taken together, our results demonstrate that oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to the activation of CD8+ TEMs, providing a novel mechanism by which oxidative stress initiates autoimmunity in vitiligo.

Keywords: CD8(+) T cell; IL-15; Keratinocyte; Oxidative stress; Vitiligo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Betamethasone / analogs & derivatives
  • Betamethasone / pharmacology
  • CD8-Positive T-Lymphocytes / cytology
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / metabolism*
  • Coculture Techniques
  • Drug Combinations
  • Gene Expression Regulation
  • Humans
  • Hydrogen Peroxide / metabolism
  • Interleukin-15 / genetics*
  • Interleukin-15 / metabolism
  • Janus Kinase 1 / genetics*
  • Janus Kinase 1 / metabolism
  • Keratinocytes / drug effects
  • Keratinocytes / metabolism*
  • Keratinocytes / pathology
  • Lymphocyte Activation / drug effects
  • Melanocytes / drug effects
  • Melanocytes / metabolism
  • Melanocytes / pathology
  • Oxidative Stress
  • Primary Cell Culture
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Receptors, Interleukin-15 / antagonists & inhibitors
  • Receptors, Interleukin-15 / genetics
  • Receptors, Interleukin-15 / metabolism
  • STAT3 Transcription Factor / genetics*
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction
  • Transcription Factor RelA / antagonists & inhibitors
  • Transcription Factor RelA / genetics
  • Transcription Factor RelA / metabolism
  • Vitiligo / genetics*
  • Vitiligo / metabolism
  • Vitiligo / pathology

Substances

  • Anti-Inflammatory Agents
  • Drug Combinations
  • IL15 protein, human
  • IL15RA protein, human
  • Interleukin-15
  • RNA, Small Interfering
  • Receptors, Interleukin-15
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Transcription Factor RelA
  • betamethasone dipropionate, betamethasone sodium phosphate drug combination
  • Betamethasone
  • Hydrogen Peroxide
  • JAK1 protein, human
  • Janus Kinase 1